Summary
The purpose of this review was to focus on hospital admissions caused by a specific type of adverse drug reaction (ADR) that can be assumed to be avoidable in almost all cases: the drug-drug interaction (D-DI). To determine the epidemiology of D-DIs in hospital admissions, a review of the adverse drug reaction literature was undertaken to answer several questions: (a) what is the incidence of hospital admissions attributable to D-DIs?; (b) what percentage of drug-related hospital admissions are attributable to D-DIs?; (c) are there any patterns to the above findings, i.e. are some D-DIs or specific drugs more likely to have been associated with hospital admissions?; and (d) are there certain patient risk factors (e.g. age) that are associated with D-DIs that led to a hospital admission?
Nine ADR studies were found that either included a D-DI category as a cause for hospital admissions, or provided sufficient information so that a causal relationship could be inferred. The incidence of hospital admissions due to D-DIs ranged from 0 to 2.8%. The data found in the studies we reviewed, however, were insufficient to allow meaningful quantification of specific drugs as usual causes for D-DI-related admissions, and because of the very small numbers of patients for which a D-DI was believed to be the cause it is not possible to provide a meaningful summary of risk factors specific for D-DI admissions.
We cannot conclude that D-DIs are a significant problem. There is a need to view the quantification of D-DIs in relation to the number of medications prescribed by physicians, dispensed by pharmacists and taken by patients.
Similar content being viewed by others
References
Bergman U, Wilholm BE. Drug-related problems causing admission to a medical clinic. European Journal of Clinical Pharmacology 20: 193–200, 1981
Bero LA, Lipton HL, Bird JA. Characterization of geriatric drug-related hospital readmissions. Medical Care 21: 989–1003, 1991
Borda IT, Slone D, Jick H. Assessment of adverse reactions within a drug surveillance program. Journal of the American Medical Association 205: 99–101, 1968
Boston Collaborative Drug Surveillance Program. Adverse drug interactions. Journal of the American Medical Association 220: 1238–1239, 1972
Caranasos GJ, Stewart RB, Cluff LE. Drug-induced illness leading to hospitalization. Journal of the American Medical Association 228: 713–717, 1974
Colt HG, Shapiro. Drug-induced illness as a cause for admission to a community hospital. Journal of the American Geriatrics Society 37: 323–326, 1989
Davidsen F, Haghfelt T, Gram LF, Brøsen K. Adverse drug reactions and drug non-compliance as primary causes of admission to a cardiology department. European Journal of Clinical Pharmacology 34: 83–86, 1988
Federal Council on Aging, U.S. Department of Health and Human Services. The need for long term care: information and issues, DHHS Publications (OHDS) 81-20704, US Government Printing Office, Washington, DC, 1981
Ford DR, Rivers NP, Wood GC. A computerized detection system for potentially significant adverse drug-drug interactions. Journal of the American Pharmaceutical Association 17: 354–357, 1977
Frisk PA, Cooper JW, Campbell NA. Community-hospital pharmacist detection of drug related problems upon admission to small hospitals. American Journal of Hospital Pharmacy 34: 738–742, 1977
Gibson RM, Mueller MS, Fisher CR. Age differences in health care spending, fiscal year 1976. Social Security Bulletin 40: 3, 1977
Grymonpre RE, Mitenko PA, Sitar DS, Aoki FY, Montgomery PR. Drug-associated hospital admissions in older medical patients. Journal of the American Geriatrics Society 36: 1092–1098, 1988
Hallas J, Gram LF, Grodum E, Damsbo N, Brosen K, et al. Drug related admissions to medical wards: a population based survey. British Journal of Clinical Pharmacology 33: 61–68, 1992
Hansten PD, Horn JR. Patients at increased risk for adverse drug interactions. Drug Interactions Newsletter 10: 589–595, 1990
Hurwitz N. Predisposing factors in adverse reactions to drugs. British Medical Journal 1: 536–539, 1969
Ibáñez L, Laporte JR, Carne X. Adverse drug reactions leading to hospital admission. Drug Safety 6: 450–459, 1991
Ives TJ, Benkz EJ, Gwyther RE. Drug-related admissions to a family medicine inpatient service. Archives of Internal Medicine 147: 1117–1120, 1987
Jankel CA, Speedie SM. Detecting drug interactions: a review of the literature. DICP: Annals of Pharmacotherapy 24: 982–989, 1990
Jick H. Adverse drug reactions: the magnitude of the problem. Journal of Allergy and Clinical Immunology 74: 555–557, 1984
Karch FE, Lasagna L. Adverse drug reactions: a critical review. Journal of the American Medical Association 234: 1236–1241, 1975
Klein LE, German PS, Levine DM. Adverse drug reactions among the elderly: a reassessment. Journal of the American Geriatrics Society 29: 525–530, 1981
Koch H. Drug utilization in office practice by age and sex of the patient: national ambulatory medical care survey, 1980. Advance Data 81: 1–12, 1982
Kwan TC, Wahba WW, Wildeman RA. Drug interactions: a retrospective study of its epidemiology, clinical significance and influence upon hospitalization. Canadian Journal of Hospital Pharmacy 32: 12–16, 1979
Lakshmanan MC, Hershey CO, Breslau D. Hospital admissions caused by iatrogenic disease. Archives of Internal Medicine 146: 1931–1934, 1986
Levy M, Lipshitz M, Eliakim M. Hospital admissions due to adverse drug reactions. American Journal of the Medical Sciences 277: 49–56, 1979
McKenney JM, Harrison WL. Drug-related hospital admissions. American Journal of Hospital Pharmacy 33: 792–795, 1976
Miller RR. Hospital admissions due to adverse drug reactions: a report from the Boston Collaborative Drug Surveillance Program. Archives of Internal Medicine 134: 219–223, 1974
Ogilvie Rl, Ruedy J. Adverse drug reactions during hospitalization. Journal of the Canadian Medical Association 97: 1450–1457, 1967
Prince BS, Goetz CM, Rihn TL, Olsky M. Drug-related emergency department visits and hospital admissions. American Journal of Hospital Pharmacy 49: 1696–1700, 1992
Puckett WH, Visconti JA. An epidemiological study of the clinical significance of drug-drug interactions in a private community hospital. American Journal of Hospital Pharmacy 28: 247–253, 1971
Smith JW, Seidl LG, Cluff LE. Studies on the epidemiology of adverse drug reactions: V. Clinical factors influencing susceptibility. Annals of Internal Medicine 65: 629–640, 1966
Tatro DS (Ed.). Drug interaction facts, J.B. Lippincott Co., St Louis, 1992
Trunet P, LeGall JR, Lhoste F, Regnier B, Saillard Y, et al. The role of iatrogenic disease in admissions to intensive care. Journal of the American Medical Association 244: 2617–2620, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jankel, C.A., Fitterman, L.K. Epidemiology of Drug-Drug Interactions as a Cause of Hospital Admissions. Drug-Safety 9, 51–59 (1993). https://doi.org/10.2165/00002018-199309010-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199309010-00005